HSA — authorised 16 June 2023
- Marketing authorisation holder: SPECTRUM PHARMS
- Status: likely_approved
🇸🇬 ROLVEDON in Singapore
HSA authorised ROLVEDON on 16 June 2023
Marketing authorisation
ROLVEDON in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is ROLVEDON approved in Singapore?
Yes. HSA authorised it on 16 June 2023.
Who is the marketing authorisation holder for ROLVEDON in Singapore?
SPECTRUM PHARMS holds the Singaporean marketing authorisation.